SOLV
Solventum Corp
NYSE · Healthcare · Medical - Care Facilities · US
$88.84
+1.50%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.37
- Revenue estimate
- $1.9B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $2.55
- EPS estimate
- $1.90
- Revenue actual
- $2.2B
- Revenue estimate
- $2.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +16.3%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $98
- PT range
- $81 – $105
- Analysts
- 7
6 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $1.90 | $2.55 | Beat 34.21% | $2.2B |
| May 5, 2026 | $1.35 | $1.48 | Beat 9.63% | $2.0B |
| Nov 6, 2025 | $1.43 | $1.50 | Beat 4.90% | $2.1B |
| Aug 7, 2025 | $1.45 | $1.69 | Beat 16.55% | $2.2B |
| May 8, 2025 | $1.21 | $1.34 | Beat 10.74% | $2.1B |
| Feb 27, 2025 | $1.31 | $1.41 | Beat 7.63% | $2.1B |
| Nov 7, 2024 | $1.39 | $1.64 | Beat 17.99% | $2.1B |
| Aug 8, 2024 | $1.51 | $1.56 | Beat 3.31% | $2.1B |
| May 9, 2024 | $1.75 | $2.08 | Beat 18.86% | $2.0B |
| Dec 30, 2023 | — | $0.42 | — | $2.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026